Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/13711
Title: | Topical delivery of Anti-VEGF nanomedicines for treating psoriasis |
Authors: | Pandey, Murali Monohar Chitkara, Deepak Mittal, Anupama |
Keywords: | Pharmacy Psoriasis Vascular endothelium growth factor Nanomedicine Topical delivery |
Issue Date: | May-2023 |
Publisher: | Elsevier |
Abstract: | Psoriasis is a chronic skin disease characterized by inflammation caused by the activation of the immune system. Although the etiology of psoriasis is still unknown, the crosstalk between immune cells, dermal vascular cells, and epidermal keratinocytes has been shown as a critical process. Curiously, the overexpression of vascular endothelium growth factor (VEGF), which further propagates angiogenesis and cell proliferation, helps in the progression of the psoriasis plaque. Literature evidence shows the betterment of the psoriasis plaque when administering anti-VEGFA treatment. In our opinion, several other therapies targeting VEGF/VEGFR axis, such as employing peptides, RNAi and CRISPRi with nanocarriers as delivery strategy could redirect the therapeutic approach for the treatment of psoriasis. Collectively, this short communication highlights the significance of VEGFA, its downstream targets, and nanomedicines in the treatment of psoriasis. Nevertheless, continued research in this area could enable novel therapeutics and strategies to enter the market with a substantial social impact. |
URI: | https://www.sciencedirect.com/science/article/pii/S1773224723002174 http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13711 |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.